Clinical Trial

Vitamin D3 Supplementation in Patients With HIV: Effects on Interleukin-6 Levels and CD4 Counts

Completed
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the effect of Vitamin D3 supplementation on inflammatory markers and immune status in patients with HIV who are receiving antiretroviral therapy. Participants will receive Vitamin D3 supplementation for 3 months. Outcomes including Interleukin-6 levels and CD4 counts will be measured to assess the potential benefits of this intervention.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-22.
Trial Details
NCT Number NCT07553052
Lead Sponsor Universitas Sebelas Maret
Collaborators: Dr. Moewardi General Hospital, Surakarta, Indonesia
Conditions Human Immunodeficiency Virus (HIV)
Enrollment 20 participants
Start Date 2025-06-01
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-15